Data / Form D filings / SURGE Therapeutics, Inc.
SURGE Therapeutics, Inc.: Form D filings
SURGE Therapeutics, Inc., a biotechnology company in Cambridge, MA, filed 2 Form D notices with the SEC between 2020 and 2023. The latest, on June 2, 2023, reports $32 million sold of a $50 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE BROADWAY, 14TH FLOOR, Cambridge, MA, 02142
- Phone
- (617) 909-8181
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1834664
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2023 | New notice | $49,999,998 | $32,003,969 | $17,996,029 | 22 | May 19, 2023 | sec.gov |
| Dec 4, 2020 | New notice | $29,634,446 | $20,634,443 | $9,000,003 | 5 | Nov 23, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gary S. Goldberg | Director | |
| Michael S. Goldberg | Executive Officer, Director | |
| Jason S. Coloma | Director | |
| Chuck S. Carignan | Executive Officer | |
| Antonio S. Gualberto | Executive Officer | |
| Kouki S. Harasaki | Director | |
| Ali S. Farahanchi | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 29, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SURGE Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.